新天药业(002873.SZ)发布前三季度业绩，归母净利润1618.09万元，同比下降73.47%

Core Viewpoint - New Tian Pharmaceutical (002873.SZ) reported a significant decline in both revenue and net profit for the first three quarters of 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company achieved an operating revenue of 559 million yuan, representing a year-on-year decrease of 15.47% [1] - The net profit attributable to shareholders was 16.18 million yuan, down 73.47% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 13.55 million yuan, reflecting a year-on-year decline of 67.93% [1]